Nomura Holdings’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-35,200
Closed -$140K 1900
2025
Q4
$140K Buy
35,200
+10,000
+40% +$44.3K ﹤0.01% 1814
2025
Q3
$95.3K Buy
+25,200
New +$85.5K ﹤0.01% 1812
2024
Q1
Sell
-23,000
Closed -$43.7K 1815
2023
Q4
$43.7K Sell
23,000
-374,085
-94% -$559K ﹤0.01% 1700
2023
Q3
$524K Sell
397,085
-46,000
-10% -$101K ﹤0.01% 1119
2023
Q2
$1.32M Sell
443,085
-27,915
-6% -$89.7K ﹤0.01% 822
2023
Q1
$1.63M Buy
471,000
+29,993
+7% +$145K 0.01% 872
2022
Q4
$1.84M Sell
441,007
-2,172,207
-83% -$8.22M 0.01% 717
2022
Q3
$10.5M Buy
2,613,214
+8,000
+0.3% +$60.7K 0.04% 328
2022
Q2
$28.3M Buy
+2,605,214
New +$31.2M 0.1% 124
2021
Q4
Sell
-4,107
Closed -$292K 2340
2021
Q3
$292K Buy
4,107
+107
+3% +$7.74K ﹤0.01% 1568
2021
Q2
$323K Buy
+4,000
New +$264K ﹤0.01% 1567

Other funds holding NBP

Nomura Holdings's NBP Position: Q1 2026 in Review

Nomura Holdings sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2026, closing a stake of 35,200 shares — an estimated $140K sold.

Nomura Holdings first reported a position in NBP in Q2 2021 and held it in 11 quarters. The position peaked at $28.3M in Q2 2022. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

  • Nomura Holdings reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2026 after selling out during the quarter.
  • Nomura Holdings sold 35,200 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $140K.
  • Nomura Holdings first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 11 quarters.
  • Nomura Holdings's NovaBridge Biosciences American Depositary Shares position peaked at $28.3M in Q2 2022.
  • 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.